ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CRIS vs CELZ // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Curis Inc. (NASDAQ) VS. Creative Medical Technology Holdings Inc. (NASDAQ) • 15-METRIC TALLY: CRIS 2 — CELZ 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRIS VS. CELZ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CRIS CELZ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 63.40% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -13.40% -45.50% +32.10 CRIS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 3/9 -2.00 CELZ /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 42.2 31.7 +10.45 CRIS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.7M $5.2M -$1.5M CELZ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CRIS REV CELZ REV CRIS GROSS % CELZ GROSS % CRIS FCF CELZ FCF
FY 2025 $9.4M $6.0K — 63.4% -$27.2M -$5.9M
FY 2024 $10.9M $11.0K — 60.0% -$39.6M -$5.3M
FY 2023 $10.0M $9.0K — — -$38.4M -$8.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRIS // BETA —
CELZ // BETA —